Bumps in the Road: Panniculitis in Children and Adolescents Treated with Vemurafenib

2017 
Vemurafenib is increasingly being used to treat nonmelanoma tumors that are positive for the BRAF V600E mutation. We report three children who presented with panniculitis induced by vemurafenib while undergoing treatment for central nervous system tumors and review the literature.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    10
    References
    9
    Citations
    NaN
    KQI
    []